BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/4/2021 1:47:10 PM | Browse: 350 | Download: 611
 |
Received |
|
2021-02-18 12:33 |
|
Peer-Review Started |
|
2021-02-18 12:40 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-16 05:45 |
|
Revised |
|
2021-03-30 05:10 |
|
Second Decision |
|
2021-04-16 13:03 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-04-21 03:26 |
|
Articles in Press |
|
2021-04-21 03:26 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-05-05 11:00 |
|
Typeset the Manuscript |
|
2021-05-21 01:37 |
|
Publish the Manuscript Online |
|
2021-06-04 13:47 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Minireviews |
| Article Title |
New perspectives on angiotensin-converting enzyme 2 and its related diseases
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Li-Ping Liu, Xiao-Li Zhang and Jian Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81873861 |
| Key Grant of Research and Development in Hunan Province |
2020DK2002 |
|
| Corresponding Author |
Jian Li, PhD, Associate Professor, Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, School of Medicine, Hunan Normal University, No. 371 Tong Zhi Po Road
, Changsha 410013, Hunan Province, China. lijianyxy@hunnu.edu.cn |
| Key Words |
Angiotensin-converting enzyme 2; COVID-19; Salt; Renin-angiotensin-system inhibitors; Diabetes and cardiovascular disease; Renal and lung disease |
| Core Tip |
Angiotensin-converting enzyme 2 (ACE2) as the key cell receptor for severe acute respiratory syndrome coronavirus 2 virus has received widespread attention. This review will review the new perspectives on ACE2 and covers available information on the host regulative factors of ACE2 and discusses its role in a variety of pathophysiological conditions. This review will help us with a better understanding of ACE2’s biological function and its role in coronavirus disease 2019 infection and treatment. |
| Publish Date |
2021-06-04 13:47 |
| Citation |
Liu LP, Zhang XL, Li J. New perspectives on angiotensin-converting enzyme 2 and its related diseases. World J Diabetes 2021; 12(6): 839-854 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i6/839.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i6.839 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
